EUVIMEDEUVIMED entdecken
Crossref

Design, synthesis, antimicrobial activity, DFT, and molecular docking studies of pyridine‐pyrazole‐based dihydro‐1,3,4‐oxadiazoles against various bacterial and fungal targets

Nisheeth Desai, Dharmpalsinh Jadeja, Jahnvi Monapara, Saroj Kumar Panda, Malay Kumar Rana, Bharti Dave

Journal of Biochemical and Molecular Toxicology · 2023

DOI: 10.1002/jbt.23377 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2023. Verfasst von Nisheeth Desai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medicinal Chemistry, Department of Chemistry, Mahatma Gandhi Campus, Maharaja Krishnakumarsinhji Bhavnagar University, Bhavnagar, India. Hauptthemen laut MEDLINE: Oxadiazoles, Anti-Infective Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance which is increasing at an alarming rate is a severe public health issue worldwide. Hence, the development of novel antibiotics is an urgent need as microbes have developed resistance against available antibiotics. In search of novel antimicrobial agents, a convenient route for the preparation of substituted 3‐(1‐phenyl‐3‐( p ‐tolyl)‐1 H ‐pyrazol‐4‐yl)‐1‐(2‐phenyl‐5‐(pyridin‐3‐yl)‐1,3,4‐oxadiazol‐3(2 H )‐yl)prop‐2‐en‐1‐ones ( 6a – 6o ) has been adopted by using pyridine‐3‐carbohydrazide and various aromatic aldehydes. The newly synthesized compounds were characterized by using various spectral techniques, for example, IR, 1 H NMR, 13 C NMR, and mass spectroscopy. Synthesized hybrids were studied for in vitro antimicrobial potency against various bacterial and fungal strains. Antibacterial results revealed that compounds 6e, 6h, 6i, 6l , and 6m were found to be most active against bacterial strains as they showed minimum inhibitory concentration (MIC) value of 62.5 μg/mL while compounds 6d, 6e , and 6h showed MIC value of 200 μg/mL against Candida albicans . The quantum parameters that relate to the bioavailability of the compounds were computed, followed by docking with different bacterial and fungal targets like sortase A, dihydrofolate reductase, thymidylate kinase, gyrase B, sterol 14‐alpha demethylase. The experimental and computational results are in good agreement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxadiazolesAnti-Infective AgentsStructure-Activity RelationshipMolecular Docking SimulationAnti-Bacterial AgentsBacteriaMicrobial Sensitivity TestsPyrazolesPyridinesMolecular Structure

Stichwörter der Autor:innen

antimicrobial activitydihydro-1,3,4-oxadiazolemolecular dockingpyrazolepyridine

Substanzen

OxadiazolesAnti-Bacterial AgentsAnti-Infective AgentsPyrazolesPyridines

Autor:innen und Institutionen

  • Division of Medicinal Chemistry, Department of Chemistry, Mahatma Gandhi Campus, Maharaja Krishnakumarsinhji Bhavnagar University, Bhavnagar, India.
  • Department of Chemical Sciences, Indian Institute of Science Education and Research (IISER) Berhampur, Odisha, India.
  • School of Science, Indrashil University, Kadi, Gujarat, India.

Zitieren

APA

Desai, N., Jadeja, D., Monapara, J., Panda, S. K., Rana, M. K., & Dave, B. (2023). Design, synthesis, antimicrobial activity, DFT, and molecular docking studies of pyridine‐pyrazole‐based dihydro‐1,3,4‐oxadiazoles against various bacterial and fungal targets. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.23377

Vancouver

Desai N, Jadeja D, Monapara J, Panda SK, Rana MK, Dave B. Design, synthesis, antimicrobial activity, DFT, and molecular docking studies of pyridine‐pyrazole‐based dihydro‐1,3,4‐oxadiazoles against various bacterial and fungal targets. Journal of Biochemical and Molecular Toxicology. 2023. doi:10.1002/jbt.23377

BibTeX
@article{Desai2023,
  author = {Desai, Nisheeth and Jadeja, Dharmpalsinh and Monapara, Jahnvi and Panda, Saroj Kumar and Rana, Malay Kumar and Dave, Bharti},
  title = {Design, synthesis, antimicrobial activity, DFT, and molecular docking studies of pyridine‐pyrazole‐based dihydro‐1,3,4‐oxadiazoles against various bacterial and fungal targets},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2023},
  doi = {10.1002/jbt.23377}
}
Kostenlos starten →